Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Immune checkpoint blockade (ICB) has shown the high potential in treating various cancers [1], [2]. However, only a small number of patients profit from this treatment strategy [3]. The effectiveness of this strategy in other patients is hampered by the “cold” tumor characteristics of inferior immunogenicity and inadequate infiltration of T cells [4], [5], [6].
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
